Connected Drug Delivery Devices Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, Japan, China, India, Australia, Argentina, Brazil, Mexico, South Africa, Saudi Arabia, UAE), Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI4422
Connected Drug Delivery Devices Market size is projected to experience substantial progress from 2019 to 2025.
Connected drug delivery devices are wireless & digitally connected electronic appliances that facilitate patient treatment effectively. They are cost-efficient and user-friendly devices. Also, for development of innovative devices, the manufacturing firms are aiming on alliance with software firms to incorporate the cloud data system in digital devices.
Global Connected Drug Delivery Devices Market, By Region, 2018 (USD Million)
Get more details on this report - Request Free Sample PDF
The swift technical developments & rising spending in healthcare sector is pushing business growth. Moreover, mounting elderly population coupled with rising consciousness about harmful impacts of non-adherence to treatment is propelling market evolution. In addition, soaring adoption of machine learning, artificial intelligence (AI) & big data analytics in medical technology for real-time assessment is projected to offer lucrative growth opportunity during the forecast time.
Non-adherence to prescribed drugs is a key element for heightened disease problem and healthcare expenses. The impact of non-adherence can lead to reduced product utilization, varied patient outcomes, and reduced drug selling. Smart drug delivery devices are utilized for enhancing patient trust for prescribed medicines by doctors. Hence, boosting awareness involving adverse impacts of non-adherence is expected to foster business growth. Moreover, alertness about benefits of connected devices over traditional ones is further anticipated to fuel product necessity, thus advancing this industry in the future. However, concerns regarding patient safety & data insecurity is projected to be considerable factor hampering market progress.
The global connected drug delivery devices market is categorized into device types, technology, application, end-use and region. The product type is further segmented into connected sensors and integrated devices. The integrated devices segment is expected to register significant growth in the global market. Inhalers are commonly used device for curing respiratory disorders such as chronic obstructive pulmonary disease, asthma, anaphylaxis etc. Thereby, rise in prevalence of respiratory diseases will create high demand for digital inhalers. Additionally, launch of novel inhalers such as, FindAir One Device, that wirelessly connects to web & mobile apps for easy usage of patients and doctors will boost the segmental expansion.
On the basis of technology, the products are categorized into bluetooth, Near Field Communication (NFC), and Wi-fi. Bluetooth segment is expected to witness lucrative growth in study period. A huge number of connected drug delivery techniques use Bluetooth technology owing to easily availability and affordability as compared to other technologies. For instance, BIOCORP’s Datapen & Propeller Health’s add-on sensor used in respiratory inhalers work on bluetooth technology. Furthermore, this technology is well-suited with nearly all smartphones available in market. This is likely to push the segment growth over foreseeable years.
On the basis of application, the market is categorized into anaphylaxis, respiratory, cardiovascular, diabetes, hormone replacement and others. Diabetes segment is expected to witness profitable growth in the study period. Sedentary lifestyle and suboptimal diet leads to high blood sugar levels, thus increasing the chances of diabetes. Therefore, soaring prevalence of diabetes mellitus cases around the world will create high demand for bluetooth & wi-fi connected insulin delivery devices. In addition, escalating usage of smart phones coupled with advanced diabetes management apps is likely to promote the segment expansion.
End-use segment is sectored into hospitals, clinics & homecare. The hospital segment is expected to witness a lucrative growth in estimated time frame. Rising cases of anaphylaxis, diabetes, cardiovascular diseases, respiratory disorders & other chronic illnesses will escalate the demand for effective health record devices. These digitally connected drug devices can resolve this obstacle by examining drug dosage & delivery along with efficiently preserving patient data. Thus, rising prevalence of chronic disorders & adoption of advanced technology will augment the segmental growth.
U.S. accounted for the largest revenue share in the North America market and is expected to lead over the forecast period. High growth is attributed to quick adoption of latest technologies and smart devices coupled with artificial intelligence and big data analytics. Moreover, high per capita healthcare expenditure and rising awareness regarding the adverse effects of non-adherence to medication will propel growth of market in the country. Additionally, presence of major market players in this region coupled with their growing efforts to enhance their product portfolio will positively impact progress of the U.S. market.
Some of the major market players involved in the global connected drug delivery devices market are Bayer AG, 3M, BioCorp Production SA, Cohero Health, Propeller Health, OPKO Health and Adherium among few other players. Strategic initiatives such as launch of novel digital drug delivery products, acquisitions and merger strategies are being adopted by these firms to fortify their business growth. For instance, in August 2018, Adherium, a leading digital health platform provider launched the Hailie solution in the U.S. The Hailie solution helped patients with asthma & COPD to access better care coupled with digital experience that includes a smartphone application, accessible for iOS & android. The introduction of newer products is expected to propel growth of market in near future.
Connected Drug Delivery Devices Market, By Device Type, 2014-2025 (USD Million)
- Connected Sensors
- Connected Inhalation Sensors
- Connected Injectable Sensors
- Integrated Devices
- Integrated Inhalation Devices
- Integrated Injectable Devices
- Handheld Injectable Devices
- Wearable Injectable Devices
Connected Drug Delivery Devices Market, By Technology, 2014-2025 (USD Million)
- Near Field Communication
Connected Drug Delivery Devices Market, By Application, 2014-2025 (USD Million)
- Hormone Replacement
Connected Drug Delivery Devices Market, By End-use, 2014-2025 (USD Million)
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- South Africa
- Saudi Arabia
- Amiko Digital Health Limited
- Bayer AG
- BioCorp Production
- Care TRx
- Cohero Health
- Findair Sp. z o. o.
- OPKO Health
- Propeller Health
- West Pharmaceutical Services
- Teva Pharmaceuticals
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Benefits of Association
Data Coverage & Quality
GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.
Client Trust & Security
GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.
Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.